Trials / Completed
CompletedNCT02818361
Topical Tripterygium Wilfordii Gel for Moderate Activity Rheumatoid Arthritis
Topical Tripterygium Wilfordii Gel for Treatment in Patients With Moderate Activity Rheumatoid Arthritis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 70 (actual)
- Sponsor
- Guang'anmen Hospital of China Academy of Chinese Medical Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Tripterygium wilfordii Hook F (TwHF), a traditional Chinese herb, is widely used in China for treating Rheumatoid Arthritis (RA), but limited only for elderly RA patients because of its reproductive system toxicity. The investigators are inspired by Chinese external therapy, an immemorial therapy for thousands of years, and take its advantage to make TwHF topically in order to get an effective and safe treatment for active RA patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Topical tripterygium gel | |
| DRUG | Placebo gel |
Timeline
- Start date
- 2012-04-01
- Primary completion
- 2013-03-01
- Completion
- 2013-12-01
- First posted
- 2016-06-29
- Last updated
- 2018-11-20
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02818361. Inclusion in this directory is not an endorsement.